Grown Rogue International Stock Today
| GRUSF Stock | USD 0.66 0.01 1.54% |
Performance3 of 100
| Odds Of DistressLess than 26
|
Grown Rogue is trading at 0.66 as of the 26th of November 2024. This is a 1.54 percent increase since the beginning of the trading day. The stock's lowest day price was 0.64. Grown Rogue has about a 26 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Grown Rogue International are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of August 2024 and ending today, the 26th of November 2024. Click here to learn more.
Grown Rogue International Inc., through its subsidiaries, engages in growing and selling cannabis products in the United States. Grown Rogue International Inc. is headquartered in Medford, Oregon. Grown Rogue operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.. The company has 170.63 M outstanding shares. More on Grown Rogue International
Moving against Grown OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Grown OTC Stock Highlights
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Grown Rogue International [GRUSF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with a current market capitalization of 20.48 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Grown Rogue's market, we take the total number of its shares issued and multiply it by Grown Rogue's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Grown Rogue International classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 170.63 M outstanding shares.
Grown Rogue International has accumulated about 1.53 M in cash with (238.46 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Grown Rogue Probability Of Bankruptcy
Ownership AllocationGrown Rogue International has a total of 170.63 Million outstanding shares. Grown Rogue secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Grown Ownership Details
Grown Rogue International Risk Profiles
| Mean Deviation | 3.06 | |||
| Semi Deviation | 3.36 | |||
| Standard Deviation | 3.78 | |||
| Variance | 14.27 |
Grown Stock Against Markets
Picking the right benchmark for Grown Rogue otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Grown Rogue otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Grown Rogue is critical whether you are bullish or bearish towards Grown Rogue International at a given time. Please also check how Grown Rogue's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Grown Rogue without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
| All Next | Launch Module |
Grown Rogue Corporate Management
Elected by the shareholders, the Grown Rogue's board of directors comprises two types of representatives: Grown Rogue inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Grown. The board's role is to monitor Grown Rogue's management team and ensure that shareholders' interests are well served. Grown Rogue's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Grown Rogue's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Buddy Wilson | VP Sales | Profile | |
| Steven Lightman | Special CEO | Profile | |
| Adam August | VP LLC | Profile | |
| Obie Strickler | CEO Pres | Profile | |
| Ryan Kee | Chief CFO | Profile |
Other Information on Investing in Grown OTC Stock
Grown Rogue financial ratios help investors to determine whether Grown OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Grown with respect to the benefits of owning Grown Rogue security.